Eris Lifesciences Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Glimisave MV 2.3 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimisave MV 2.3 Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimisave MV 2.3 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimisave MV 2.3 Tablet SR.
Glimisave MV 2.3 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimisave MV 2.3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimisave MV 2.3 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimisave MV 2.3 Tablet SR contains a combination of three active ingredients: Glimepiride, Metformin and Voglibose. This medicine is prescribed for the management of type 2 diabetes mellitus (DM) in adults. It helps to improve blood glucose levels by working together with dietary changes and exercise routines.
Like many medications, Glimisave MV 2.3 Tablet SR can have potential side effects. These may include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
It's important to avoid using Glimisave MV 2.3 Tablet SR if you have known allergies to any components or excipients of the medicine. Additionally, individuals with moderate to severe kidney disease and those with inflammatory bowel diseases, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis should avoid taking this medication.
No, the combination of Glimisave MV 2.3 Tablet SR and alcohol is not recommended. It may lower your blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, using Glimisave MV 2.3 Tablet SR may result in hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It can be triggered by missing meals or drinks, excessive alcohol intake, over-exercise, or taking other antidiabetic medications simultaneously.
Store Glimisave MV 2.3 Tablet SR in its original packaging, tightly sealed. Follow the instructions provided on the label or package. Do not consume any leftover medication and ensure it is out of reach from pets, children, and unauthorized individuals.